PEX11 Antibody

What are the major PEX11 isoforms detected by commercially available antibodies?

There are three major PEX11 isoforms in mammals: PEX11α, PEX11β, and PEX11γ. Each isoform has distinct expression patterns and functions. PEX11β is expressed throughout different tissues but has higher expression levels in tissues with high metabolic activity such as the liver, brain, and kidneys . Commercial antibodies are available for all three isoforms, with PEX11β antibodies being particularly well-characterized for research applications across multiple species including human, mouse, and rat samples .

How do PEX11 isoforms differ in their biological functions?

PEX11 proteins are involved in peroxisomal proliferation, but each isoform appears to have specialized functions. PEX11β plays a direct role in peroxisome division by promoting membrane protrusion and elongation on the peroxisomal surface . It also recruits the dynamin-related GTPase DNM1L to the peroxisomal membrane, which is essential for proper peroxisome division . Studies with knockout mice have shown that loss of PEX11β causes reduced peroxisome abundance even in the absence of peroxisomal metabolic substrates, and affects multiple peroxisomal metabolic pathways including ether lipid synthesis and very long chain fatty acid oxidation .

What criteria should be used when selecting a PEX11 antibody for specific applications?

When selecting a PEX11 antibody, researchers should consider:

• Target specificity: Ensure the antibody specifically recognizes your PEX11 isoform of interest

• Species reactivity: Verify that the antibody has been validated in your experimental species (human, mouse, rat)

• Application compatibility: Check if the antibody has been validated for your intended application (WB, IHC, IF)

• Epitope location: Consider whether the antibody targets a conserved or variable region of the protein

• Validation data: Review published literature and manufacturer data showing antibody specificity

For instance, the PEX11B antibody (ab211508) has been validated for Western blot and IHC-P applications with human, mouse, and rat samples , while the PEX11G antibody (15744-1-AP) has been tested in WB, IF, IHC, and ELISA applications with human and mouse samples .

How can researchers verify the specificity of PEX11 antibodies?

To verify antibody specificity, researchers should:

• Run positive controls: Use tissues known to express high levels of PEX11 (liver, kidney, brain for PEX11β)

• Include negative controls: Use samples where the target protein is absent or knockdown/knockout models

• Verify molecular weight: Confirm that the detected band matches the expected size (28 kDa for PEX11B, 27 kDa for PEX11G)

• Cross-validate with multiple antibodies: Use antibodies targeting different epitopes

• Perform peptide competition assays: Pre-incubate the antibody with the immunizing peptide

The expected molecular weight for PEX11B is 28 kDa, which can be observed in Western blots of MCF-7, Raw264.7, and PC12 cell lysates . Similarly, PEX11G displays an observed molecular weight of 27 kDa .

What are the optimal conditions for Western blot analysis of PEX11 proteins?

Based on validated protocols, the following conditions are recommended for Western blot analysis of PEX11 proteins:

For optimal results, researchers should use fresh samples, include appropriate loading controls, and optimize transfer conditions for these relatively small membrane proteins .

What immunohistochemistry protocols yield the best results for PEX11 detection?

For immunohistochemical detection of PEX11 proteins:

• Fixation: Use formalin-fixed, paraffin-embedded (FFPE) tissue sections

• Antigen retrieval: For PEX11G, use TE buffer pH 9.0 (alternatively, citrate buffer pH 6.0)

• Antibody dilutions:

  • PEX11B (ab211508): 1:200 dilution has been validated for human breast tissue

  • PEX11G (15744-1-AP): 1:20-1:200 dilution range is recommended for human kidney tissue

• Detection system: Use a compatible secondary antibody and visualization system

• Counterstain: Hematoxylin is typically used for nuclear contrast

Researchers should always include positive and negative controls to ensure specificity of staining patterns.

How can PEX11 antibodies be used to study peroxisome dynamics and proliferation?

PEX11 antibodies are valuable tools for investigating peroxisome dynamics:

• Time-course experiments: PEX11β overexpression studies reveal a sequence of peroxisomal morphological changes, beginning with normal appearance (1.5-2h), followed by elongation (4-8h), and finally a large increase in peroxisome abundance (24-48h) .

• Quantitative analysis: Immunofluorescence microscopy with PEX11 antibodies can be used to quantify peroxisome abundance. For example, cells expressing PEX11βmyc showed approximately 964 ± 341 peroxisomes per section (pps), representing a 1,000% increase compared to control cells (99 ± 39 pps) .

• Co-localization studies: PEX11 antibodies can be combined with markers for other peroxisomal proteins (e.g., catalase, PEX14) to study peroxisome biogenesis and dynamics. Studies in PEX11β+/+ cells showed an average peroxisome abundance of 230 ± 52 pps, while PEX11β−/− cells showed approximately half that amount (128 ± 32 pps) .

• Live-cell imaging: When combined with fluorescent protein tagging, PEX11 antibodies can help validate experimental systems for studying peroxisome division in real-time.

What are the key considerations when using PEX11 antibodies in knockout or knockdown models?

When using PEX11 antibodies in knockout or knockdown models:

• Verify knockout efficiency: Use PEX11 antibodies to confirm the absence of target protein expression in knockout models or reduced expression in knockdown models.

• Monitor compensatory mechanisms: In PEX11 knockout models, check for potential upregulation of other PEX11 isoforms using isoform-specific antibodies.

• Assess phenotypic consequences: PEX11β knockout mice show reduced peroxisome abundance and deficiencies in multiple peroxisomal metabolic pathways, which can be monitored using appropriate antibodies for peroxisomal enzymes .

• Control for non-specific effects: Include appropriate controls to ensure that observed effects are due to PEX11 deficiency rather than secondary effects of the experimental system.

• Consider tissue-specific effects: The impact of PEX11 loss may vary across tissues, particularly between tissues with high metabolic activity (liver, brain, kidneys) versus those with lower metabolic demands .

What are common issues encountered with PEX11 antibodies and how can they be resolved?

When troubleshooting, remember that PEX11 proteins are membrane-bound, which can present unique challenges for extraction and detection .

How should researchers interpret contradictory data between different PEX11 antibodies?

When faced with contradictory results from different PEX11 antibodies:

• Examine antibody epitopes: Determine if the antibodies recognize different regions of the PEX11 protein, which might explain discrepancies.

• Assess antibody validation: Review how thoroughly each antibody has been validated for your specific application and species.

• Consider protein modifications: Different antibodies may have varying sensitivities to post-translational modifications or protein conformations.

• Evaluate experimental conditions: Small differences in sample preparation, buffers, or detection methods can impact results.

• Use orthogonal approaches: Complement antibody-based methods with mRNA analysis or functional assays.

• Consult the literature: Check if similar discrepancies have been reported and how they were resolved.

How can PEX11 antibodies contribute to understanding the relationship between peroxisome dynamics and metabolic function?

The relationship between peroxisome dynamics and metabolism can be explored using PEX11 antibodies through:

• Metabolic challenge experiments: Use PEX11 antibodies to monitor peroxisome abundance and morphology in response to metabolic stimuli.

• Correlation studies: Combine PEX11 antibody staining with assays for peroxisomal metabolic functions (e.g., fatty acid oxidation, ether lipid synthesis).

• Temporal analyses: Track the sequence of peroxisomal proliferation and metabolic adaptation using time-course experiments.

• Comparative analysis of PEX11 isoforms: Studies have shown that PEX11 proteins promote peroxisome division independently of peroxisome metabolism, challenging earlier hypotheses that PEX11 has a direct role in medium chain fatty acid oxidation .

• Disease model investigations: PEX11β−/− mice show deficiencies in both ether lipid synthesis and very long chain fatty acid oxidation, suggesting that PEX11 proteins affect multiple, unrelated peroxisomal metabolic activities indirectly .

What emerging techniques combine PEX11 antibodies with other methodologies for advanced peroxisome research?

Emerging research approaches combining PEX11 antibodies with other techniques include:

• Super-resolution microscopy: Combining PEX11 antibodies with techniques like STORM or PALM to visualize peroxisome ultrastructure beyond the diffraction limit.

• Proximity labeling: Using techniques like BioID or APEX2 fused to PEX11 to identify novel interaction partners at the peroxisomal membrane.

• Single-cell analyses: Applying PEX11 antibodies in single-cell proteomics or imaging to understand cell-to-cell variability in peroxisome abundance and function.

• Tissue clearing techniques: Combining PEX11 antibodies with tissue clearing methods to visualize peroxisome distribution in intact tissues or organs.

• Correlative light and electron microscopy (CLEM): Using PEX11 antibodies to identify regions of interest for subsequent ultrastructural analysis by electron microscopy.

These advanced approaches can provide novel insights into the role of PEX11 proteins in peroxisome biology and related metabolic disorders.